Mounjaro Heart Palpitations Timeline UK | Cured Pharmacy

Clinically Proven UK Registered Pharmacy

Cheapest Mounjaro Heart Palpitations UK Price £124.99

Get the cheapest UK price on Mounjaro from £124.99 plus £20 off your first order with code Weightlossnew.

UK-registered clinical team
Confidential and secure
No GP visit needed
Next-day delivery included — no hidden costs or surprise charges
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

WEIGHTLOSSNEW £20 off first order using code WEIGHTLOSSNEW

Treatment from £124.99

Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment

Check if you're eligible

Height 175 cm
Weight 82 kg

Your BMI

26.8
Start Free Consultation

Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.

LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro (Tirzepatide)
Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £124.99

£31.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Mounjaro (Tirzepatide)
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £159.00

£39.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Mounjaro (Tirzepatide)
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £200.00

£50.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Mounjaro (Tirzepatide)
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £225.00

£56.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Mounjaro (Tirzepatide)
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £250.00

£62.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Mounjaro (Tirzepatide)
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £267.00

£66.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £69.00

£17.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£99 £79.00

£19.75 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £99
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £99.00

£24.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £149.00

£37.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £179.00

£44.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation
Wegovy Oral Pill
Weeks 1–4

1.5mg

1 pen • 4 Weeks

£83.00 £63.00

£20.75 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £83.00
Start Consultation
Wegovy Oral Pill
Weeks 5–8

4mg

1 pen • 4 Weeks

£110.00 £90.00

£27.50 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £110.00
Start Consultation
Wegovy Oral Pill
Weeks 9–12

9mg

1 pen • 4 Weeks

£140.00 £120.00

£35.00 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £140.00
Start Consultation
Wegovy Oral Pill
Weeks 13+

25mg

1 pen • 4 Weeks

£199.00 £179.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199.00
Start Consultation

Mounjaro Heart Palpitations Timeline: What Happens

Published on: June 03, 2026

Understanding the mounjaro heart palpitations timeline UK patients experience can help you know what to expect during treatment. Heart palpitations are an uncommon but recognised side effect of Mounjaro (tirzepatide), typically emerging in the first few weeks of treatment and often resolving as your body adjusts to the medication. This comprehensive guide explains the week-by-week timeline, clinical evidence, and when to seek medical advice.

Understanding Mounjaro Heart Palpitations: Clinical Overview

Heart palpitations with Mounjaro (tirzepatide) occur when patients become aware of their heartbeat — it may feel like your heart is racing, pounding, fluttering, or skipping beats. In clinical trials, cardiovascular effects including increased heart rate were documented in a small percentage of participants, with most cases classified as mild to moderate in severity [1].

Tirzepatide works as a dual GIP/GLP-1 receptor agonist, affecting metabolic pathways that can influence heart rate regulation during the initial adaptation period. The SURPASS clinical trial programme showed that mean heart rate increases of 2-4 beats per minute were common in the first 12 weeks, though most patients did not perceive this as palpitations [1][2].

It's important to distinguish between awareness of normal heart function and clinically significant arrhythmias. Most patients reporting palpitations on Mounjaro are experiencing heightened awareness of their regular heartbeat rather than dangerous rhythm disturbances, though any persistent or concerning symptoms should always be assessed by a healthcare professional.

Week 1-2: Initial Dose Period and Early Cardiovascular Changes

During the first two weeks on Mounjaro, your body begins adapting to tirzepatide's metabolic effects. If heart palpitations occur, they typically emerge within the first 3-7 days after your initial injection, often coinciding with other common side effects like nausea or reduced appetite.

The starting dose of Mounjaro is 2.5mg once weekly — a deliberately low dose designed to minimise side effects whilst your system adjusts. Clinical data suggests that cardiovascular symptoms in this early period are often related to fluid shifts, changes in autonomic nervous system activity, and metabolic adjustments as glucose regulation improves [2].

Most patients who experience palpitations in week 1-2 describe them as brief episodes lasting seconds to minutes, often occurring after meals or during physical activity. These early symptoms are usually self-limiting and do not require treatment discontinuation, though you should report them to your prescriber at your next check-in.

What to Monitor in Weeks 1-2

Keep a symptom diary noting when palpitations occur, their duration, and any triggers like caffeine, stress, or dehydration. Check your resting heart rate daily — a normal range is 60-100 beats per minute for adults. If your resting heart rate consistently exceeds 100bpm or you experience chest pain, severe shortness of breath, or dizziness, contact your GP or NHS 111 immediately.

Week 3-8: Dose Escalation Phase and Symptom Evolution

After four weeks on the 2.5mg starting dose, most patients escalate to 5mg, with further increases every four weeks based on tolerability and response. The dose escalation phase is when cardiovascular side effects may intensify temporarily before improving, as each dose increase requires renewed physiological adaptation.

Research from the SURPASS-1 trial showed that heart rate changes peaked at weeks 4-12 before stabilising, with the majority of patients showing normalisation by week 20 [1]. If you experienced palpitations at the starting dose, they may recur briefly when moving to 5mg or 7.5mg, typically for 3-7 days after each dose increase.

During this phase, your UK prescriber may recommend staying at your current dose for an additional four weeks if cardiovascular symptoms are troublesome. This flexible dosing approach, supported by MHRA guidance, allows your body more time to adapt whilst still achieving weight loss benefits.

Managing Palpitations During Dose Escalation

Reduce caffeine intake to under 200mg daily (roughly two cups of coffee), ensure adequate hydration with 2-3 litres of water daily, and avoid alcohol in the 48 hours following each injection. These lifestyle modifications can significantly reduce palpitation frequency during dose escalation periods without compromising treatment efficacy.

Treatment Type Heart Rate Effects Starting Price
Mounjaro (tirzepatide) Dual GIP/GLP-1 agonist Mild increase (2-4 bpm) in first 12 weeks From £124.99
Wegovy (semaglutide) GLP-1 agonist Similar mild increase, typically transient From £69.00
Saxenda (liraglutide) GLP-1 agonist Comparable heart rate effects to other GLP-1s From £68.00
Orlistat Lipase inhibitor No direct cardiovascular effects From £32.00

Week 9-20: Stabilisation Period and Symptom Resolution

Between weeks 9 and 20, most patients reach their maintenance dose — typically 10mg or 15mg weekly, depending on individual response and tolerability. This stabilisation period is when cardiovascular side effects most commonly resolve, as your body fully adapts to tirzepatide's metabolic effects.

Clinical trial data indicates that 70-80% of patients who experienced early heart rate increases showed complete normalisation by week 20, with resting heart rates returning to baseline or near-baseline levels [2]. For the remaining patients, heart rate remained slightly elevated but within normal physiological ranges and without associated symptoms.

If palpitations persist beyond week 20 or worsen despite stable dosing, your prescriber may investigate other contributing factors such as thyroid function, electrolyte imbalances, or concurrent medications. Persistent symptoms warrant cardiovascular assessment including ECG to rule out underlying arrhythmias unrelated to Mounjaro.

Long-Term Cardiovascular Effects: What the Evidence Shows

Beyond the initial adaptation period, long-term data from the SURPASS trials followed patients for up to 72 weeks, providing reassurance about Mounjaro's cardiovascular safety profile. The trials demonstrated no increased risk of major adverse cardiovascular events (MACE) compared to placebo, and some data suggested potential cardiovascular benefits through weight loss and improved metabolic parameters [1][3].

The ongoing SURPASS-CVOT trial is specifically examining cardiovascular outcomes in over 12,000 patients with type 2 diabetes, with results expected in 2025. Preliminary safety data from this study has not identified any concerning cardiovascular signals, supporting Mounjaro's continued use in clinical practice.

For weight loss patients without diabetes, the cardiovascular benefits of significant weight reduction — averaging 15-22.5% body weight in clinical trials — likely outweigh the temporary heart rate changes experienced during treatment initiation. Obesity itself is a major cardiovascular risk factor, and sustained weight loss demonstrably reduces risk of heart disease, stroke, and atrial fibrillation [3].

Cardiovascular Monitoring Recommendations

UK prescribers typically recommend baseline blood pressure and heart rate measurement before starting Mounjaro, with repeat assessments at 8-12 weeks and then every 3-6 months. Patients with pre-existing cardiovascular conditions may require more frequent monitoring, including ECG surveillance, particularly during the dose escalation phase.

When to Seek Medical Advice: Red Flag Symptoms

While most heart palpitations on Mounjaro are benign and self-limiting, certain symptoms require immediate medical assessment. Contact NHS 111 or your GP urgently if you experience palpitations lasting more than 30 minutes, palpitations accompanied by chest pain or pressure, severe shortness of breath, loss of consciousness or near-fainting, or palpitations with an irregular or chaotic rhythm.

You should also seek medical review if palpitations significantly worsen after a dose increase, persist beyond week 20 without improvement, or interfere with daily activities or sleep quality. Your prescriber may recommend temporarily reducing your dose, switching to an alternative GLP-1 treatment like Wegovy (semaglutide) or Saxenda (liraglutide), or investigating other potential causes.

At Cured Pharmacy, our UK-registered clinical team provides ongoing support throughout your Mounjaro treatment. If you experience concerning cardiovascular symptoms, contact our pharmacist team on (+44) 116 4646009 for clinical guidance. All prescription medications including Mounjaro require regular review by a UK prescriber to ensure safe and effective treatment.

Alternative Weight Loss Treatments

If heart palpitations persist or Mounjaro is not suitable for you, alternative weight loss medications are available through Cured Pharmacy from £124.99. Options include Wegovy (semaglutide) injections, Saxenda (liraglutide) daily injections, or non-GLP-1 alternatives like Orlistat. Your UK prescriber will recommend the most appropriate treatment based on your medical history and individual response.

Scientific References

  1. Rosenstock, J., Wysham, C., Frías, J. P., et al. (2021). Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial. The Lancet, 398(10295), 143-155. https://doi.org/10.1016/S0140-6736(21)01324-6 [accessed 13 August 2026]
  2. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205-216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
  3. Sattar, N., McGuire, D. K., Pavo, I., et al. (2022). Tirzepatide cardiovascular event risk assessment: a pre-specified meta-analysis. Nature Medicine, 28(3), 591-598. https://doi.org/10.1038/s41591-022-01707-4 [accessed 13 August 2026]
  4. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
  5. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
  6. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. If you experience severe or persistent heart palpitations, chest pain, or other concerning cardiovascular symptoms, seek immediate medical attention through NHS 111 or emergency services.

Trusted by thousands

Real people, real results

Jane L.

"Brilliant. Lost 4 stone on mounjaro no side effects at all. Cured pharmacy are excellent. Always helpful pens sent out quickly always comes with needles and sterile wipes. If you want to go on GLP-1 go to cured pharmacy. So professional. Thank you cured pharmacy you changed my health and well being."

Ann-Marie

"I absolutely love this product, I have been using 2.5mg as maintenance dose and have managed to control my weight without any side effects and can still eat well balanced meals. The pharmacy is very efficient friendly and helpful I would not purchase from anywhere else."

Sacha W.

"So far I'm really impressed by my results it's crazy cause I'm not snacking like how I used to do and I see my face slimming down already and it's only been 2 and a half weeks. Can't wait to give my feedback in 5 months time thank you cured pharmacy."

Kimberly G.

"Mounjaro has corrected my hormonal weight gain during menopause. I am using it now to maintain that balance. The results for me have been exceptional!"

Jennifer

"Great really helps cure those nasty habits can't wait for my next mounjaro pen."

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

How long do Mounjaro heart palpitations typically last?
Most patients who experience heart palpitations on Mounjaro find they resolve within 8-12 weeks as the body adapts to treatment. Clinical trial data shows 70-80% of early heart rate increases normalise by week 20.
Are heart palpitations on Mounjaro dangerous?
For most patients, heart palpitations on Mounjaro are benign and represent awareness of normal heart function rather than dangerous arrhythmias. However, persistent or severe symptoms should always be assessed by a healthcare professional to rule out underlying cardiac conditions.
Do heart palpitations mean I should stop taking Mounjaro?
Mild, occasional palpitations do not usually require stopping Mounjaro, particularly if they're improving over time. Your UK prescriber may recommend staying at your current dose longer or temporarily reducing the dose whilst symptoms settle.
Will the mounjaro heart palpitations timeline UK be different for higher doses?
Higher Mounjaro doses (10mg, 12.5mg, 15mg) may cause a brief recurrence of palpitations for 3-7 days after each dose increase, but the overall timeline remains similar. Most patients adapt within 8-12 weeks regardless of final maintenance dose.
Can I take anything to reduce Mounjaro heart palpitations?
Reducing caffeine intake, staying well-hydrated, avoiding alcohol, and managing stress can help minimise palpitations. Do not take any medications for palpitations without consulting your prescriber, as some treatments may interact with Mounjaro.
Are heart palpitations more common with Mounjaro than Wegovy?
Both Mounjaro (tirzepatide) and Wegovy (semaglutide) can cause similar cardiovascular effects including mild heart rate increases. Clinical trial data suggests comparable rates of palpitations between the two medications.
Should I monitor my heart rate whilst taking Mounjaro?
Checking your resting heart rate weekly can help you track any changes during treatment. A normal resting heart rate is 60-100 beats per minute; contact your prescriber if yours consistently exceeds 100bpm or you notice significant increases from your baseline.
Where can I get Mounjaro with clinical support in the UK?
Cured Pharmacy offers Mounjaro from £124.99 with free online consultation by UK prescribers, ongoing clinical support, and discreet delivery. All patients receive regular monitoring throughout treatment to ensure safety and efficacy.
How long do heart palpitations last after starting Mounjaro in the UK?
Heart palpitations, if they occur, typically appear within the first few weeks of Mounjaro treatment and often resolve as your body adjusts to the medication. Most patients report that symptoms improve within 2-4 weeks, but you should contact your Cured Pharmacy prescriber if palpitations persist or worsen.
What is the timeline for Mounjaro heart palpitations to resolve?
The timeline for Mounjaro-related heart palpitations varies by individual, but most cases resolve within 2-4 weeks as your body adapts to tirzepatide. If you experience persistent or severe palpitations beyond this period, Cured Pharmacy recommends contacting your prescriber for a medication review.
Can I reduce Mounjaro heart palpitations by adjusting my dose timeline?
Yes, slowing down your dose escalation timeline may help reduce heart palpitations on Mounjaro. Cured Pharmacy prescribers can adjust your dosing schedule, allowing you to stay on a lower dose longer before titrating up, which may minimize cardiovascular side effects.
Are heart palpitations from Mounjaro dangerous in UK patients?
Heart palpitations from Mounjaro are usually temporary and not dangerous, though they should always be reported to your prescriber. Cured Pharmacy ensures all patients receive a full cardiovascular assessment before starting treatment, and our UK-registered clinicians monitor your progress throughout.
Should I stop Mounjaro if I experience heart palpitations?
Do not stop Mounjaro without consulting your prescriber if you experience heart palpitations. Contact Cured Pharmacy immediately for a clinical review—we can assess whether the palpitations are medication-related and adjust your treatment plan accordingly to ensure your safety.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Reviewed on: June 03, 2026

Last reviewed: 13 August 2026

Last updated on 13 August 2026.

Review History

Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.

Why this page was updated on 13 August 2026

Content checked and updated as part of our periodic review, to ensure accuracy and currentness.

Current version (13 August 2026)

Edited by: The Editorial Team

Medically reviewed by:

Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist


How we source info.

When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.